Wellesley, MA – Harvard Pilgrim Health Care has signed a value-based contract with Eli Lilly & Company for its osteoporosis drug, Forteo, which will measure patients’ adherence to the drug. The contract was developed to address the challenge of ensuring that patients keep taking the medication as prescribed by their physician.
Wellesley, MA – Harvard Pilgrim Health Care has signed an innovative outcomes contract based on therapy effectiveness with Amgen for its rheumatoid arthritis drug, Enbrel. This contract represents another move by Harvard Pilgrim to reimburse based on value to the patient, and not solely on volume of medicine sold.
DiCicco, Gulman & Company LLP (DGC), a CPA and business consulting firm announced that it has risen to the position of 14th largest accounting firm on the Boston Business Journal’s list of The Largest Accounting Firms in Massachusetts. This is up from 15th last year. When considering the non-national firms on the list, DGC ranks 5th largest.
Waltham, MA, December 27, 2016 – The Smaller Business Association of New England (SBANE) is proud to announce a “Call for Nominations” for the prestigious 2017 New England Innovation Awards. SBANE is proud recognize innovation as the key to economic prosperity. SBANE’s prestigious award program is kicking off the 32nd year of celebrating New England’s Innovation Economy. Since 1986, the New England Innovation Awards has recognized companies’ innovations that have been game changers in their given field.
A research team at the Harvard Medical School Department of Population Medicine at the Harvard Pilgrim Health Care Institute has been approved for a $3.2 million funding award by the Patient- Centered Outcomes Research Institute (PCORI) to compare outcomes for adults and children with asthma in high-deductible health plans with and without preventive drug lists.